Liminal BioSciences Inc. PFSCF

Primary Symbol: LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc.

Bullboard Posts

Post by mmaltaison Jan 18, 2019 4:03pm

204 Views

Post# 29253510

Transaction at the close

Goldman Sachs at the close 218,000 shares. Cross trade

Time		Price	Shares	Change	Exch/Mkt	Buyer	Seller
01/18/2019 4:00 PM EST	Q	0.315	200	0.02	TSX	002	065
01/18/2019 4:00 PM EST	Q	0.315	123	0.02	TSX	002	002
01/18/2019 4:00 PM EST	Q	0.315	200	0.02	TSX	065	002
01/18/2019 4:00 PM EST	Q	0.315	218,000	0.02	TSX	065	065
01/18/2019 3:59 PM EST	E	0.31	492	0.02	TSX	007	001
01/18/2019 3:59 PM EST		0.315	2,000	0.02	TSX	001	001
01/18/2019 3:59 PM EST		0.315	3,500	0.02	TSX	001	001
01/18/2019 3:59 PM EST	E	0.31	8	0.02	TSX	002	001